Similar articles for PMID: 25450876

Year	Number of Results
1991	1
1995	2
1997	3
1999	1
2002	1
2004	6
2005	4
2006	1
2007	5
2008	2
2009	3
2010	6
2011	6
2012	3
2013	8
2014	6
2015	11
2016	8
2017	12
2018	7
2019	7
2020	4
2021	2
2022	11
2023	1
2024	0

1

Radical-intent hypofractionated radiotherapy for locally advanced non-small-cell lung cancer: a systematic review of the literature.

Kaster TS, Yaremko B, Palma DA, Rodrigues GB. Kaster TS, et al. Clin Lung Cancer. 2015 Mar;16(2):71-9. doi: 10.1016/j.cllc.2014.08.002. Epub 2014 Sep 28. Clin Lung Cancer. 2015. PMID: 25450876 Review.

2

Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)-Lung Working Group.

Parisi G, Mazzola R, Ciammella P, Timon G, Fozza A, Franceschini D, Navarria F, Bruni A, Perna M, Giaj-Levra N, Alongi F, Scotti V, Trovo M. Parisi G, et al. Radiol Med. 2019 Feb;124(2):136-144. doi: 10.1007/s11547-018-0950-z. Epub 2018 Oct 27. Radiol Med. 2019. PMID: 30368721

3

Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial.

Ren XC, Wang QY, Zhang R, Chen XJ, Wang N, Liu YE, Zong J, Guo ZJ, Wang DY, Lin Q. Ren XC, et al. BMC Cancer. 2016 Apr 23;16:288. doi: 10.1186/s12885-016-2314-1. BMC Cancer. 2016. PMID: 27108080 Free PMC article. Clinical Trial.

4

Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer.

Kepka L, Tyc-Szczepaniak D, Bujko K. Kepka L, et al. J Thorac Oncol. 2009 Jul;4(7):853-61. doi: 10.1097/JTO.0b013e3181a97dda. J Thorac Oncol. 2009. PMID: 19487965 Free article.

5

Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer.

Kong C, Zhu X, Shi M, Wang L, Chen C, Tao H, Jiang N, Yan P, Zhao L, Song X, He X. Kong C, et al. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):710-719. doi: 10.1016/j.ijrobp.2020.03.038. Epub 2020 Apr 7. Int J Radiat Oncol Biol Phys. 2020. PMID: 32275994 Clinical Trial.

6

Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?

de Dios NR, Sanz X, Foro P, Membrive I, Reig A, Ortiz A, Jiménez R, Algara M. de Dios NR, et al. Clin Transl Oncol. 2017 Apr;19(4):440-447. doi: 10.1007/s12094-016-1544-7. Epub 2016 Aug 23. Clin Transl Oncol. 2017. PMID: 27553602

7

Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction).

Valeriani M, Marinelli L, Nicosia L, Reverberi C, De Sanctis V, Mollo D, Osti MF. Valeriani M, et al. Radiol Med. 2019 Dec;124(12):1324-1332. doi: 10.1007/s11547-019-01064-2. Epub 2019 Jul 17. Radiol Med. 2019. PMID: 31317381

8

Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.

Pollom EL, Qian Y, Durkee BY, von Eyben R, Maxim PG, Shultz DB, Gensheimer M, Diehn M, Loo BW Jr. Pollom EL, et al. Clin Lung Cancer. 2016 Nov;17(6):588-594. doi: 10.1016/j.cllc.2016.05.024. Epub 2016 Jun 8. Clin Lung Cancer. 2016. PMID: 27378172

9

Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.

Wang J, Xia TY, Wang YJ, Li HQ, Li P, Wang JD, Chang DS, Liu LY, Di YP, Wang X, Wu WZ. Wang J, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e59-65. doi: 10.1016/j.ijrobp.2010.12.035. Epub 2011 Feb 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 21345607

10

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in Chinese population: A retrospective study.

Xu Y, Zheng X, Bai X, Li P, Ma H, Wang J, Hu X, Chen M. Xu Y, et al. Oncotarget. 2017 Jul 25;8(30):49084-49092. doi: 10.18632/oncotarget.17094. Oncotarget. 2017. PMID: 28467775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year